BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10750591)

  • 1. Catecholamines in cardiac hypertrophy.
    Scheuer J
    Am J Cardiol; 1999 Jun; 83(12A):70H-74H. PubMed ID: 10750591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.
    Simpson P
    Circ Res; 1985 Jun; 56(6):884-94. PubMed ID: 2988814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium.
    Long CS; Hartogensis WE; Simpson PC
    J Mol Cell Cardiol; 1993 Aug; 25(8):915-25. PubMed ID: 7505339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renin-angiotensin system in cardiac hypertrophy.
    Yamazaki T; Komuro I; Yazaki Y
    Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy.
    Bogoyevitch MA; Andersson MB; Gillespie-Brown J; Clerk A; Glennon PE; Fuller SJ; Sugden PH
    Biochem J; 1996 Feb; 314 ( Pt 1)(Pt 1):115-21. PubMed ID: 8660271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.
    Osadchii OE
    Heart Fail Rev; 2007 Mar; 12(1):66-86. PubMed ID: 17387610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic modulation of the cardiac myocyte phenotype: studies with a cell-culture model of myocardial hypertrophy.
    Long CS; Kariya K; Karns L; Simpson PC
    Basic Res Cardiol; 1992; 87 Suppl 2():19-31. PubMed ID: 1338564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell contact as an independent factor modulating cardiac myocyte hypertrophy and survival in long-term primary culture.
    Clark WA; Decker ML; Behnke-Barclay M; Janes DM; Decker RS
    J Mol Cell Cardiol; 1998 Jan; 30(1):139-55. PubMed ID: 9500872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic hormones and control of cardiac myocyte growth.
    Simpson PC; Kariya K; Karns LR; Long CS; Karliner JS
    Mol Cell Biochem; 1991 May 29-Jun 12; 104(1-2):35-43. PubMed ID: 1656195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines modulate protein turnover in cultured, quiescent rabbit cardiac myocytes.
    Decker RS; Cook MG; Behnke-Barclay MM; Decker ML; Lesch M; Samarel AM
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H329-39. PubMed ID: 8342650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcolemmal α2-adrenoceptors control protective cardiomyocyte-delimited sympathoadrenal response.
    Kokoz YM; Evdokimovskii EV; Maltsev AV; Nenov MN; Nakipova OV; Averin AS; Pimenov OY; Teplov IY; Berezhnov AV; Reyes S; Alekseev AE
    J Mol Cell Cardiol; 2016 Nov; 100():9-20. PubMed ID: 27659409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of adrenergic receptor system in canine left ventricular hypertrophy].
    Shida M
    Kokyu To Junkan; 1989 Mar; 37(3):321-7. PubMed ID: 2525269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines.
    Simpson P; McGrath A; Savion S
    Circ Res; 1982 Dec; 51(6):787-801. PubMed ID: 6216022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac findings in experimental uremia.
    Rambausek M; Mann JF; Mall G; Kreusser W; Ritz E
    Contrib Nephrol; 1986; 52():125-33. PubMed ID: 2952457
    [No Abstract]   [Full Text] [Related]  

  • 18. Network integration of the adrenergic system in cardiac hypertrophy.
    Barki-Harrington L; Perrino C; Rockman HA
    Cardiovasc Res; 2004 Aug; 63(3):391-402. PubMed ID: 15276464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trophic factors for cardiac myocytes.
    Long CS; Kariya K; Karns L; Simpson PC
    J Hypertens Suppl; 1990 Dec; 8(7):S219-24. PubMed ID: 1965655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic regulation of cardiac myocyte apoptosis.
    Singh K; Xiao L; Remondino A; Sawyer DB; Colucci WS
    J Cell Physiol; 2001 Dec; 189(3):257-65. PubMed ID: 11748583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.